Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries

T. Katakura, T. Yoshida, Makiko Kobayashi, David Herndon, Fujio Suzuki

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA), is a major cause of sepsis in patients who are immunosuppressed by their burns. In this study, an immunological regulation of MRSA infection was attempted in a mouse model of thermal injury. SCIDbg mice were resistant to MRSA infection, while SCIDbgMN mice (SCIDbg mice depleted of neutrophils and macrophages (MΦ)) were susceptible to the same infection. Also, thermally injured SCIDbg mice were shown to be susceptible to MRSA infection. On the other hand, the resistance of SCIDbgMN mice to the infection was completely recovered after an inoculation with MΦ from normal mice. However, anti-MRSA resistance was not shown in SCIDbgMN mice inoculated with MΦ from thermally injured mice. MΦfrom MRSA-infected thermally injured mice were identified as alternatively activated MΦ and MΦfrom MRSA-infected unburned mice were characterized as classically activated MΦ. MΦ from thermally injured SCIDbg mice previously treated with 2-carboxyethylgermanium sesquioxide (Ge-132) protected SCIDbgMN mice against MRSA infection. Ge-132 has been described as an inhibitor of alternatively activated MΦ, generation. These results suggest that MRSA infection in thermally injured patients is controlled immunologically through the induction of anti-MRSA effector cells and elimination of burn-associated alternatively activated MΦ, which are cells that inhibit the generation of classically activated MΦ.

Original languageEnglish (US)
Pages (from-to)419-425
Number of pages7
JournalClinical and Experimental Immunology
Volume142
Issue number3
DOIs
StatePublished - Dec 2005

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Hot Temperature
Wounds and Injuries
Infection
Burns
Staphylococcus aureus
Sepsis
Neutrophils
Macrophages

Keywords

  • Macrophages
  • MRSA
  • Thermal injury

ASJC Scopus subject areas

  • Immunology

Cite this

Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries. / Katakura, T.; Yoshida, T.; Kobayashi, Makiko; Herndon, David; Suzuki, Fujio.

In: Clinical and Experimental Immunology, Vol. 142, No. 3, 12.2005, p. 419-425.

Research output: Contribution to journalArticle

@article{b4c8b844cc0d4b7bb94b370e09b7d7b7,
title = "Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries",
abstract = "Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA), is a major cause of sepsis in patients who are immunosuppressed by their burns. In this study, an immunological regulation of MRSA infection was attempted in a mouse model of thermal injury. SCIDbg mice were resistant to MRSA infection, while SCIDbgMN mice (SCIDbg mice depleted of neutrophils and macrophages (MΦ)) were susceptible to the same infection. Also, thermally injured SCIDbg mice were shown to be susceptible to MRSA infection. On the other hand, the resistance of SCIDbgMN mice to the infection was completely recovered after an inoculation with MΦ from normal mice. However, anti-MRSA resistance was not shown in SCIDbgMN mice inoculated with MΦ from thermally injured mice. MΦfrom MRSA-infected thermally injured mice were identified as alternatively activated MΦ and MΦfrom MRSA-infected unburned mice were characterized as classically activated MΦ. MΦ from thermally injured SCIDbg mice previously treated with 2-carboxyethylgermanium sesquioxide (Ge-132) protected SCIDbgMN mice against MRSA infection. Ge-132 has been described as an inhibitor of alternatively activated MΦ, generation. These results suggest that MRSA infection in thermally injured patients is controlled immunologically through the induction of anti-MRSA effector cells and elimination of burn-associated alternatively activated MΦ, which are cells that inhibit the generation of classically activated MΦ.",
keywords = "Macrophages, MRSA, Thermal injury",
author = "T. Katakura and T. Yoshida and Makiko Kobayashi and David Herndon and Fujio Suzuki",
year = "2005",
month = "12",
doi = "10.1111/j.1365-2249.2005.02944.x",
language = "English (US)",
volume = "142",
pages = "419--425",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries

AU - Katakura, T.

AU - Yoshida, T.

AU - Kobayashi, Makiko

AU - Herndon, David

AU - Suzuki, Fujio

PY - 2005/12

Y1 - 2005/12

N2 - Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA), is a major cause of sepsis in patients who are immunosuppressed by their burns. In this study, an immunological regulation of MRSA infection was attempted in a mouse model of thermal injury. SCIDbg mice were resistant to MRSA infection, while SCIDbgMN mice (SCIDbg mice depleted of neutrophils and macrophages (MΦ)) were susceptible to the same infection. Also, thermally injured SCIDbg mice were shown to be susceptible to MRSA infection. On the other hand, the resistance of SCIDbgMN mice to the infection was completely recovered after an inoculation with MΦ from normal mice. However, anti-MRSA resistance was not shown in SCIDbgMN mice inoculated with MΦ from thermally injured mice. MΦfrom MRSA-infected thermally injured mice were identified as alternatively activated MΦ and MΦfrom MRSA-infected unburned mice were characterized as classically activated MΦ. MΦ from thermally injured SCIDbg mice previously treated with 2-carboxyethylgermanium sesquioxide (Ge-132) protected SCIDbgMN mice against MRSA infection. Ge-132 has been described as an inhibitor of alternatively activated MΦ, generation. These results suggest that MRSA infection in thermally injured patients is controlled immunologically through the induction of anti-MRSA effector cells and elimination of burn-associated alternatively activated MΦ, which are cells that inhibit the generation of classically activated MΦ.

AB - Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA), is a major cause of sepsis in patients who are immunosuppressed by their burns. In this study, an immunological regulation of MRSA infection was attempted in a mouse model of thermal injury. SCIDbg mice were resistant to MRSA infection, while SCIDbgMN mice (SCIDbg mice depleted of neutrophils and macrophages (MΦ)) were susceptible to the same infection. Also, thermally injured SCIDbg mice were shown to be susceptible to MRSA infection. On the other hand, the resistance of SCIDbgMN mice to the infection was completely recovered after an inoculation with MΦ from normal mice. However, anti-MRSA resistance was not shown in SCIDbgMN mice inoculated with MΦ from thermally injured mice. MΦfrom MRSA-infected thermally injured mice were identified as alternatively activated MΦ and MΦfrom MRSA-infected unburned mice were characterized as classically activated MΦ. MΦ from thermally injured SCIDbg mice previously treated with 2-carboxyethylgermanium sesquioxide (Ge-132) protected SCIDbgMN mice against MRSA infection. Ge-132 has been described as an inhibitor of alternatively activated MΦ, generation. These results suggest that MRSA infection in thermally injured patients is controlled immunologically through the induction of anti-MRSA effector cells and elimination of burn-associated alternatively activated MΦ, which are cells that inhibit the generation of classically activated MΦ.

KW - Macrophages

KW - MRSA

KW - Thermal injury

UR - http://www.scopus.com/inward/record.url?scp=28344451788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28344451788&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2249.2005.02944.x

DO - 10.1111/j.1365-2249.2005.02944.x

M3 - Article

C2 - 16297152

AN - SCOPUS:28344451788

VL - 142

SP - 419

EP - 425

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 3

ER -